How Ostelin Cal-DK2 helps decrease bone loss
It is estimated that 66% of Australian adults have poor bone health.1 Ostelin Cal-DK2 combines the essential mineral calcium, with the benefits of vitamin D and vitamin K2, in a convenient one-a-day dose to support the maintenance of strong healthy bones and reduce the loss of bone density.
Here’s how each nutrient may be helpful for decreasing bone loss:
- Calcium – Calcium is an essential building block for lifelong bone health. Almost all calcium is stored in the bones and teeth where it supports their structure and hardness. The body also needs calcium for muscle contraction, to relax blood vessels, to send messages through the nervous system and to help release hormones and enzymes, which are required for numerous important body functions. If you don’t take in enough calcium from your diet, the body will withdraw calcium from the bones to use for these vital body processes. This means your bone density will gradually decline and you may be at risk of developing osteoporosis. Calcium supplements have been shown to maximise bone health and reduce the rate of bone loss that occurs with aging and in post-menopausal women.
- Vitamin D3 – Vitamin D plays a pivotal role in allowing the body to absorb and use calcium effectively. It promotes the absorption of dietary calcium from the gut and helps maintain optimal blood calcium levels for its various vital functions. Thereby playing an important role in developing and maintaining a healthy skeleton. Ensuring you receive enough vitamin D is critical for bone health, but evidence shows that nearly 1 in 3 Australians aren’t getting the vitamin D their bodies need.2 Taking a calcium and vitamin D supplement can help maintain peak bone mass and assist in reducing bone loss in older people.
- Vitamin K2 – Vitamin K is an often overlooked bone-building nutrient. It assists in the function of the bone protein osteocalcin, which is involved in the regulation of calcium for bone development. Vitamin K2 is the form of vitamin K used in Ostelin Cal-DK2, which has a number of advantages. It remains in the blood longer than vitamin K1, which extends its availability for use in the body. Supplementation of vitamin K2 has also been shown in clinical trials to decrease bone loss in postmenopausal women.